Oncology Institute, Inc. Quarterly Return On Equity in % from Q3 2020 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oncology Institute, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2020 to Q2 2024.
  • Oncology Institute, Inc. Return On Equity for the quarter ending June 30, 2024 was -144 %, a 157% decline year-over-year.
  • Oncology Institute, Inc. annual Return On Equity for 2023 was -107 %, a 88924% decline from 2022.
  • Oncology Institute, Inc. annual Return On Equity for 2022 was 0.12 %.
  • Oncology Institute, Inc. annual Return On Equity for 2021 was -17.5 %, a 109% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -144 -87.7 -157% Apr 1, 2024 Jun 30, 2024
Q1 2024 -114 -73 -176% Jan 1, 2024 Mar 31, 2024
Q4 2023 -107 -107 -88924% Oct 1, 2023 Dec 31, 2023
Q3 2023 -79.7 -80.5 -9792% Jul 1, 2023 Sep 30, 2023
Q2 2023 -55.8 -56.5 -8259% Apr 1, 2023 Jun 30, 2023
Q1 2023 -41.5 -52.7 -471% Jan 1, 2023 Mar 31, 2023
Q4 2022 0.12 +17.7 Oct 1, 2022 Dec 31, 2022
Q3 2022 0.82 +22.3 Jul 1, 2022 Sep 30, 2022
Q2 2022 0.68 +34.2 Apr 1, 2022 Jun 30, 2022
Q1 2022 11.2 +179 Jan 1, 2022 Mar 31, 2022
Q4 2021 -17.5 -215 -109% Oct 1, 2021 Dec 31, 2021
Q3 2021 -21.4 -178 -114% Jul 1, 2021 Sep 30, 2021
Q2 2021 -33.5 Apr 1, 2021 Jun 30, 2021
Q1 2021 -168 Jan 1, 2021 Mar 31, 2021
Q4 2020 198 Oct 1, 2020 Dec 31, 2020
Q3 2020 157 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.